The Samuel Waxman Cancer Research Foundation awards research grants to some of the best scientific minds in differentiation therapy and epigenetics all over the world. Learn about the Waxman Foundation’s grant-making process and how we choose which grants to fund each year.
LISTEN online: (Length: 2 min. 7 sec.)
Nabeel Bardeesy, Ph.D., of Massachusetts General Hospital Cancer Center is conducting vital research in pancreatic cancer. He received a $100,000 individual grant from the Waxman Foundation in 2010 to investigate new therapeutics and was the previous recipient of a collaborative grant from the Foundation. He was also the recipient of the Randy Pausch, PhD – Pancreatic Cancer Action Network – AACR Pilot Grant in 2008. Funding from both the Waxman Foundation and the Pancreatic Cancer Action Network has furthered Bardeesy’s critical work to find clues against this deadly disease.
LISTEN online: (Length: 5 min. 1 sec.)
Gwen Darien, the Executive Director of the Samuel Waxman Cancer Research Foundation, shares how she became involved in cancer research advocacy.
As an 18-year cancer survivor, Darien considers herself a beneficiary of cancer research and is keenly aware of the importance of supporting cancer research.
LISTEN online: (Length: 4 min. 40 sec.)
The Millennial Society of the Samuel Waxman Cancer Research Foundation is dedicated to raising awareness about the Foundation. The goal of the Society is to raise funds to support research in young adult cancers. Alissa Jacob, the Chair of the Millennial Society, shares why she became involved with the Society and why investing in cancer research is so crucial.
LISTEN online (Length: 4:00 minutes)
Stephen Baylin, M.D., a professor in oncology at the Johns Hopkins University School of Medicine, is a pioneer in the field of epigenetics. He discusses how researchers are learning the way genes are turned on and off to deliver therapies to cancer patients in a new way.
LISTEN online (Length: 4 min. 50 sec.)
Cancer researcher Robert A. Weinberg, Ph.D., co-founder of the Whitehead Institute for Biomedical Research in Cambridge, Mass., who discovered the first human oncogene, explains the importance of cancer stem cells and the role they play in the spread of cancer, including breast cancer.
LISTEN online (Length: 7 min, 10 sec.)
Jonathan Licht, M.D., an associate scientific director of the Samuel Waxman Cancer Research Foundation, explains how investigators have deepened their understanding of cancer research over the years and the innovative ways in which Foundation-funded investigators are trying to understand cancer’s growth and development to potentially treat the disease and prevent it.
LISTEN online (Length: 5 min, 20 sec.)
The Samuel Waxman Cancer Research Foundation (SWCRF) has awarded 13 collaborative research grants and 3 individual research grants, totaling $1.54 million. The 16 grants represent a portion of the science grant program at the Foundation, which will award more than $2 million this year to cancer research.
The grant recipients represent some of the best scientific minds in differentiation therapy—reprogramming cancer cells—a hallmark of the Waxman Foundation.
To read the full press release click here.
LISTEN online (Length: 1 min, 10 sec.)